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In response: No evidence of thalamic
metabolic abnormality associated with
continuous spike-and-wave during sleep
To the Editors:
We thank Trotta et al. for their critique and appreciate
their efforts to evaluate thalamic metabolism quan-
titatively in their cohort of patients with continuous
spike-and-wave in sleep (CSWS) using F-18-fluorodeoxy-
glucose positron emission tomography (FDG-PET).1
Although their findings contrast with our results, it is note-
worthy that their methodology remains fairly distinct.2
Even in our cohort, not everybody had thalamic abnormal-
ity. In those who did, the abnormalities ranged from hypo-
metabolism to hypermetabolism, as well as “increased
asymmetry only” with thalamic FDG uptake in the appar-
ently normal range. This emphasizes the complexity of the
issue, with thalamic metabolism perhaps getting modu-
lated by various clinical factors, which may confound the
results of small sample-size studies with the nonhomoge-
neous patient population. Furthermore, a voxel-based anal-
ysis may not be the most appropriate approach for
evaluating the aforementioned variability in thalamic FDG
uptake due to possible averaging of the uptake values at
the group level. Results of individual region-of-interest
Figure 1.
Results of the statistical comparisons between non-LKS CSWS patients and pseudo-controls (left), LKS patients and pseudo-con-
trols (middle), and LKS and non-LKS CSWS patients (right). For illustration purpose, images are thresholded at p < 0.01 uncor-
rected.
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analysis with subsequent analytical approach, as employed
in our study, might have been more comparable with our
findings.
We would like to highlight that several authors have
reported structural thalamic abnormalities in patients with
CSWS and that this relationship has been recognized for
over a decade.3–5 This association of a structural thalamic
abnormality (visible on magnetic resonance imaging
[MRI], not requiring statistical processing) and CSWS
cannot be completely discounted. Similarly, in our patient
group with CSWS and normal MRI findings, a priori quali-
tative analysis of glucose uptake on FDG-PET (by visual
analysis) revealed thalamic abnormalities in 6 of 23
patients (patients 2, 6, 8, 10, 11, and 15). Despite the differ-
ences in the quantitative methods used between Trotta
et al. and our group, it is hard to ignore this obvious pattern
of abnormalities visible to the naked eye. Therefore, we do
not concur with their conclusion that metabolic thalamic
abnormalities are not associated with CSWS, although we
do believe that this needs further exploration to be fully
explained and understood.
Although studies on functional thalamic abnormalities
in patients with CSWS are being investigated, various
clinical and genetic factors may impact the development
and pathophysiology of CSWS and thalamic abnormali-
ties. Indeed, use of a standardized methodology with a
larger patient population would be the way to go forward.
Of course, given the rarity of this condition, this may be
accomplished only by collaborative work of clinicians and
scientists with expertise and interest in CSWS and ana-
tomic/functional neuroimaging.
We acknowledge that thalamic abnormalities are seen in
patients with epilepsy without CSWS; however, the
proportion of patients who had thalamic abnormalities in
our study far exceeds the expected proportion otherwise.6
Thus, there appears to be a more specific role of thalamic
metabolic abnormalities in patients with CSWS. We con-
cur with their comment that the cortex is likely to be the
primary generator of the epileptic discharges in CSWS
patients and do not believe otherwise, but we disagree that
the thalamus is merely a propagation node. Our hypothesis
is that an abnormal thalamus leads to aberrant thalamocor-
tical interactions, which in turn leads to CSWS, although
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Elite athletes and epilepsy
To the Editors:
We read with interest the article entitled “Epilepsy,
seizures, physical exercise, and sports: A report from the
ILAE Task Force on Sports and Epilepsy.”1 The authors
suggest an approach to issuing medical fitness certificates
for people with epilepsy (PWE) based on assessing the
potential risks of seizure occurrence in different sports,
taking into account factors such as an individual’s usual
seizure characteristics (e.g., seizure type, triggers, pattern,
and severity) and willingness to accept some degree of
risk.
Despite a general move toward encouraging—rather
than limiting—involvement in sports for PWE,2
unfounded beliefs and fears regarding risks of injury and
seizure exacerbation persist and can lead to the imposition
of inappropriate restrictions by physicians or sporting bod-
ies.3–6 For athletes who develop epilepsy, such prohibi-
tions can have career-ending consequences.
We suggest an approach using objective clinical data to
counter potential barriers to participation in high-level
sports for PWE and to empower PWE to make informed
choices.
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